Literature DB >> 16236898

Lack of evidence for an association between neurofibromatosis and pulmonary fibrosis.

Jay H Ryu1, Joseph G Parambil, Pamela S McGrann, Gregory L Aughenbaugh.   

Abstract

STUDY
OBJECTIVES: To reassess the association between neurofibromatosis and pulmonary fibrosis.
DESIGN: Retrospective single-center study with analysis of patients' chest radiographs, CT scans, and medical records.
SETTING: Tertiary care, referral medical center. PATIENTS: One hundred fifty-six adult patients with neurofibromatosis seen over a 6-year period between 1997 and 2002.
RESULTS: A review of chest radiographs revealed abnormal findings in 70 patients (44.9%). The most common radiographic abnormalities were extrapulmonary nodules or masses seen in 22 patients (14.1%), followed by skeletal abnormalities in 16 patients (10.3%). Bilateral interstitial infiltrates were noted in only three patients (1.9%), all of whom had potential causes other than neurofibromatosis for their lung infiltrates, including smoking-related interstitial lung disease, rheumatoid lung disease, recurrent pneumonias, and a history of ARDS. CT scans were available in two of these patients and revealed nonspecific patterns of abnormalities with no honeycombing. Six patients had bullae or cystic airspaces demonstrated on chest radiography or CT scan; all of these findings occurred in the context of smoking-related emphysema. Combined together, bilateral interstitial lung infiltrates or cystic airspaces were demonstrated in five patients (3.2%) by chest radiography, and in eight patients (5.1%) by chest radiography or CT scanning; one patient had both findings on the CT scan.
CONCLUSIONS: We found little evidence to support an association between neurofibromatosis and pulmonary fibrosis or any other form of parenchymal lung disease. Interstitial lung disease and bullae described in association with neurofibromatosis in previous reports may have, in part, represented smoking-induced manifestations.

Entities:  

Mesh:

Year:  2005        PMID: 16236898     DOI: 10.1378/chest.128.4.2381

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

1.  Perioperative management of neurofibromatosis type 1.

Authors:  Charles J Fox; Samir Tomajian; Aaron J Kaye; Stephanie Russo; Jacqueline Volpi Abadie; Alan D Kaye
Journal:  Ochsner J       Date:  2012

Review 2.  Diffuse Cystic Lung Disease. Part II.

Authors:  Nishant Gupta; Robert Vassallo; Kathryn A Wikenheiser-Brokamp; Francis X McCormack
Journal:  Am J Respir Crit Care Med       Date:  2015-07-01       Impact factor: 21.405

3.  Diffuse lung disease in neurofibromatosis.

Authors:  Rocco Trisolini; Vanina Livi; Luigi Lazzari Agli; Marco Patelli
Journal:  Lung       Date:  2011-10-25       Impact factor: 2.584

4.  Neurofibromatosis type 1.

Authors:  Alexandre Dias Mançano
Journal:  Radiol Bras       Date:  2022 Jan-Feb

Review 5.  Diffuse cystic lung diseases.

Authors:  Jay H Ryu; Xinlun Tian; Misbah Baqir; Kaifeng Xu
Journal:  Front Med       Date:  2013-05-11       Impact factor: 4.592

6.  Lung cancer associated with neurofibromatosis type I.

Authors:  Anastasia Oikonomou; Dimitrios Mikroulis; Paraskevi Mintzopoulou; Lawal Lukman; Panos Prassopoulos
Journal:  Case Rep Radiol       Date:  2013-02-28

7.  Severe dyspnea in a patient with neurofibromatosis type 1.

Authors:  P B Poble; J C Dalphin; B Degano
Journal:  Respir Med Case Rep       Date:  2017-06-17

8.  Interstitial lung disease and pre-capillary pulmonary hypertension in neurofibromatosis type 1.

Authors:  Daniela Rodrigues; Hugo Oliveira; Carina Andrade; Luísa Carvalho; Susana Guimarães; Conceição Souto Moura; Ana Paula Vaz
Journal:  Respir Med Case Rep       Date:  2018-03-17

9.  Analysis of two cases with bronchopulmonary neurofibromatosis.

Authors:  Ting Yuan; Bai-Ling Luo; Qi-Hua Gu; Ji Yao
Journal:  Multidiscip Respir Med       Date:  2012-07-18

10.  Synchronous neuroendocrine tumor and non-small-cell lung cancer in neurofibromatosis type 1.

Authors:  Andrew Hsu; Samuel Han
Journal:  Clin Case Rep       Date:  2015-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.